Intracellular macromolecular ligands in platelets

The term 'intracellular macromolecular ligands in platelets' refers to a non-specific group of proteins, primarily tubulin, that bind and sequester certain drugs within the platelet cytoplasm (Hebden et al., 1970, British Journal of Haematology). This phenomenon is most notably associated with vinca alkaloids like vincristine and vinblastine, which are concentrated in platelets at levels significantly higher than in plasma (Jackson et al., 1978, Cancer Research). While this sequestration can protect drugs from metabolism and serve as a delivery mechanism, it also contributes to side effects such as thrombocytopenia due to the disruption of platelet function or survival (Yousif et al., 2019, Journal of Clinical Medicine). Because the term describes a heterogeneous population of binding sites rather than a single molecular entity, it is not classified as a standard therapeutic target in modern drug discovery databases. Instead, it represents a pharmacokinetic compartment that influences the distribution and toxicity of microtubule-targeting agents.

Other names

Platelet intracellular binding sitesIntracellular platelet proteinsVincristine-binding macromolecular ligands

Sequestration and concentration of drugs within platelets via binding to internal proteins such as tubulin, affecting drug distribution and platelet longevity.